 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
3 S2 j1 N. ^( v) }6 T) ?
3 b' ~" _. h5 nEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.. ~- Z' [1 f: e0 Q
) h1 _3 X; i: _7 P+ z4 [BY THE EDMONTON JOURNAL FEBRUARY 16, 2007
0 W; [& Y6 i6 n+ | C3 [% c% {! N9 i 4 V ?7 n4 P$ t3 u
9 P, |, R# ~0 H3 h+ U0 m& K4 @+ U* b
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
- P4 Q& E5 i/ t
" H2 z& m7 y0 y, T8 w# YThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
. j, A7 N+ F, g/ t- |) F U( Q( Z( a
l# b3 M: _* ~% g. \' L, sThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product. Y, n* r. H2 y4 \* J) D) G
5 |5 j& I1 M; w) CIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
, R8 }+ v! y" V" F* ^, S- X6 y/ N; K/ i/ Z
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
+ J6 N- h/ P# K/ w; W) R5 \' _" I. W' }2 a- }" J/ s9 H
"As a scientist, it's one of the highlights of my CAREER," Shan said.
# m/ f; Z( M$ T' J q7 z3 S0 Y8 K% D7 x7 X- V: J
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
0 Q0 g ]( }% k3 T- r, M, S4 f- z# H, k3 o5 Z' I4 J6 w' `
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
8 d) E; p+ e$ e; L' {+ O( u* z3 q
- r% W. d! k" G" ]Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.8 y8 d* ]! W: F: z% F9 |' `; m: `
2 U+ }: {0 N$ c3 n+ Q& L; k
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
% _/ W8 p; n. _; o: L* `6 }6 T3 _5 p i" K
* O# V" Y1 b3 z0 Khttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
; a6 x* J d: J- n7 |& L' m
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
